KRAS and cancer: While G4s have been predominantly associated with the promoters of oncogenes such as MYC, KIT or KRAS (23–25), where their stabilization is associated with suppressed oncogene expression, we explored their potential role in exonic regions and the associated impact on genomic instability in cancer patients.